Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
† Study has passed its completion date and status has not been verified in more than two years.